We serve Chemical Name:2,3-Difluorocinnamic acid CAS:207981-48-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,3-Difluorocinnamic acid
CAS.NO:207981-48-4
Synonyms:MFCD00061291;RARECHEM BK HW 0120;trans-2,3-Difluorocinnamicacid
Molecular Formula:C9H6F2O2
Molecular Weight:184.14000
HS Code:
Physical and Chemical Properties:
Melting point:200-202°C
Boiling point:281.3ºC at 760 mmHg
Density:1.45g/cm3
Index of Refraction:
PSA:37.30000
Exact Mass:184.03400
LogP:2.06260
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00061291 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trans-2,3-Difluorocinnamicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,RARECHEM BK HW 0120 Use and application,MFCD00061291 technical grade,usp/ep/jp grade.
Related News: The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term. 2,3-Difluorocinnamic acid manufacturer Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. 2,3-Difluorocinnamic acid supplier A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus. 2,3-Difluorocinnamic acid vendor The government will also send a charter flight with an Air New Zealand crew to repatriate up to 300 citizens in Wuhan. 2,3-Difluorocinnamic acid factory The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.
